Stagezero Life Sciences Stock Today
| SZLS Stock | CAD 0.04 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 66
|
StageZero Life is selling at 0.04 as of the 28th of November 2024; that is No Change since the beginning of the trading day. The stock's open price was 0.04. StageZero Life has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for StageZero Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
StageZero Life Sciences Ltd. focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. StageZero Life Sciences Ltd. The company has 123.55 M outstanding shares of which 39.71 K shares are at this time shorted by private and institutional investors with about 0.5 days to cover all short positions. More on StageZero Life Sciences
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
StageZero Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. StageZero Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding StageZero Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman of the Board, CEO | James HowardTripp | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | ||||
StageZero Life's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to StageZero Life's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsStageZero Life can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand StageZero Life's financial leverage. It provides some insight into what part of StageZero Life's total assets is financed by creditors.
| |||||
StageZero Life Sciences (SZLS) is traded on Toronto Exchange in Canada and employs 40 people. StageZero Life is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate StageZero Life's market, we take the total number of its shares issued and multiply it by StageZero Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. StageZero Life Sciences operates under Biotechnology sector and is part of Health Care industry. The entity has 123.55 M outstanding shares of which 39.71 K shares are at this time shorted by private and institutional investors with about 0.5 days to cover all short positions.
StageZero Life Sciences has accumulated about 754.87 K in cash with (809.15 K) of positive cash flow from operations.
Check StageZero Life Probability Of Bankruptcy
Ownership AllocationStageZero Life Sciences shows a total of 123.55 Million outstanding shares. StageZero Life Sciences has 19.99 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check StageZero Ownership Details
StageZero Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in StageZero Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
StageZero Life Corporate Executives
Elected by the shareholders, the StageZero Life's board of directors comprises two types of representatives: StageZero Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of StageZero. The board's role is to monitor StageZero Life's management team and ensure that shareholders' interests are well served. StageZero Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, StageZero Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| ChoongChin Liew | CoFounder | Profile |
Other Information on Investing in StageZero Stock
StageZero Life financial ratios help investors to determine whether StageZero Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in StageZero with respect to the benefits of owning StageZero Life security.